Learn about OPDIVO® (nivolumab) + YERVOY® (ipilimumab) infusions, dosing frequency, and treatment schedules for certain patients 12 years of age and older with previously treated metastatic MSI-H/dMMR colorectal cancer. See Important Safety Information.